Novo Nordisk (NVO) said Monday it has agreed to buy Benchmark Genetics, a Norwegian fish genetics company, from Benchmark Holdings for up to 260 million British pounds ($326.5 million).
Benchmark Genetics specializes in salmonid genetics, providing eggs and services to farmers in Norway, Iceland, the Faroe Islands, Chile, and other regions, Novo Nordisk said.
Price: 104.49, Change: -0.57, Percent Change: -0.54
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。